Liên hợp quốc cảnh báo nguy cơ cuộc chiến tại Yemen kéo dài

Phó Tổng Thư ký Liên hợp quốc phụ trách các vấn đề nhân đạo Mark Lowcock ngày 17/6 cảnh báo ít nhất nửa triệu người sẽ thiệt mạng nếu cuộc chiến tại Yemen tiếp diễn tới năm 2022, trong đó hơn 300.000 người chết vì đói, không được chăm sóc sức khỏe và các nguyên nhân liên quan.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh